Learning Curve Length Estimated for Minimally Invasive Distal Pancreatectomy
MONDAY, July 3, 2023 (HealthDay News) -- The learning curve length for minimally invasive distal pancreatectomy (MIDP) is estimated at 85 procedures for the primary textbook outcome (TBO), according to a study published online June 28 in JAMA Surgery.
Sanne Lof, M.D., Ph.D., from the University of Amsterdam, and colleagues examined the length of pooled learning curves for MIDP in experienced centers in a multicenter, retrospective cohort study including MIDP procedures performed from Jan. 1, 2006, through June 30, 2019, in 26 European centers from eight countries. The learning curve was assessed for the primary TBO, a composite measure reflecting optimal outcome and surgical mastery. For the secondary outcomes of operation time, intraoperative blood loss, conversion to open rate, and postoperative pancreatic fistula grade B/C, the learning curve was also assessed. The learning curve analysis was conducted on 2,041 procedures.
The researchers observed an increase and eventually a break point for TBO at 85 procedures, with the TBO rate plateauing at 70 percent. The estimated learning-associated loss of TBO rate was 3.3 percent. A break point was estimated at 40 procedures for conversion, at 56 procedures for operation time, and at 71 procedures for intraoperative blood loss. No break point could be estimated for postoperative pancreatic fistula.
"Although MIDP is considered a valuable alternative to open distal pancreatectomy, our findings suggest that it may take extensive experience to master the learning curve," the authors write.
Several authors disclosed ties to the pharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Familial Depression Linked to Cognitive Performance in Offspring
FRIDAY, April 21, 2023 (HealthDay News) -- Depression in prior generations is...
Una pastilla contra la depresión postparto se ve bien en un ensayo, y podría ser aprobada por la FDA
MIÉRCOLES, 2 de agosto de 2023 (HealthDay News) -- Esta semana, todos los ojos...
Genetic Alterations ID’d in Many Pediatric Solid Tumors
FRIDAY, July 29, 2022 (HealthDay News) -- Clinically significant genetic...
ADHD Drug Adderall in Short Supply
MONDAY, Aug. 29, 2022 (HealthDay News) -- Labor shortages at Teva...